{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:28:19Z","timestamp":1789694899400,"version":"4.0.1"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,9,15]]},"DOI":"10.2169\/internalmedicine.1098-22","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T22:12:20Z","timestamp":1675203140000},"page":"2675-2680","source":"Crossref","is-referenced-by-count":4,"title":["Malignant Hypertension and Bilateral Primary Aldosteronism"],"prefix":"10.2169","volume":"62","author":[{"given":"Sayaka","family":"Murai","sequence":"first","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Kakeshita","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Koike","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Fujioka","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 9: 133-142, 1998.","DOI":"10.1681\/ASN.V91133"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol 66: 607-618, 2007.","DOI":"10.1111\/j.1365-2265.2007.02775.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Magill SB, Raff H, Shaker JL, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 86: 1066-1071, 2001.","DOI":"10.1210\/jc.86.3.1066"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zarifis J, Lip GY, Leatherdale B, Beevers G. Malignant hypertension in association with primary aldosteronism. Blood Press 5: 250-254, 1996.","DOI":"10.3109\/08037059609079679"},{"key":"5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000185866","volume":"54","author":"M Ideishi","year":"1990","unstructured":"5. Ideishi M, Kishikawa K, Kinoshita A, et al. High-renin malignant hypertension secondary to an aldosterone-producing adenoma. Nephron 54: 259-263, 1990.","journal-title":"Nephron","ISSN":"https:\/\/id.crossref.org\/issn\/0028-2766","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Oka K, Hayashi K, Nakazato T, Suzawa T, Fujiwara K, Saruta T. Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration. Intern Med 36: 700-704, 1997.","DOI":"10.2169\/internalmedicine.36.700"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Maruhashi T, Amioka M, Kishimoto S, et al. Elevated plasma renin activity caused by accelerated-malignant hypertension in a patient with aldosterone-producing adenoma complicated with renal insufficiency. Intern Med 58: 3107-3111, 2019.","DOI":"10.2169\/internalmedicine.2327-18"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bortolotto LA, Cesena FH, Jatene FB, Silva HB. Malignant hypertension and hypertensive encephalopathy in primary aldosteronism caused by adrenal adenoma. Arq Bras Cardiol 81: 97-100, 2003.","DOI":"10.1590\/S0066-782X2003000900009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Labinson PT, White WB, Tendler BE, Mansoor GA. Primary hyperaldosteronism associated with hypertensive emergencies. Am J Hypertens 19: 623-627, 2006.","DOI":"10.1016\/j.amjhyper.2005.12.011"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol 66: 607-618, 2007.","DOI":"10.1111\/j.1365-2265.2007.02775.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Spyroglou A, Handgriff L, M\u00fcller L, et al. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects. Eur J Endocrinol 187: 361-372, 2022.","DOI":"10.1530\/EJE-22-0040"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Blumenfeld JD, Sealey JE, Schlussel Y, et al. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 121: 877-885, 1994.","DOI":"10.7326\/0003-4819-121-11-199412010-00010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hollenberg NK. Aldosterone in the development and progression of renal injury. Kidney Int 66: 1-9, 2004.","DOI":"10.1111\/j.1523-1755.2004.00701.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Young WF, Stanson AW, Thompson GB, et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 136: 1227-1235, 2004.","DOI":"10.1016\/j.surg.2004.06.051"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_1098-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:22:48Z","timestamp":1694834568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_1098-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":14,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1098-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"article-number":"1098-22"}}